Influenza Hemagglutinin (HA) Peptide: Precision Tag for Advanced Protein Workflows

Understanding the Principle: Why Choose the Influenza Hemagglutinin (HA) Peptide?

The Influenza Hemagglutinin (HA) Peptide (SKU: A6004) is a synthetic nine-amino acid sequence (YPYDVPDYA) derived from the influenza hemagglutinin protein’s epitope region. Its compact design and highly specific interaction with anti-HA antibodies make it a gold-standard molecular biology peptide tag for protein detection, purification, and immunoprecipitation workflows.

Functioning as an epitope tag for protein detection, the HA peptide is fused to a protein of interest, enabling researchers to leverage its competitive binding to anti-HA antibodies for controlled elution during immunoprecipitation or affinity purification. Notably, its exceptional solubility (≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water) and >98% purity (confirmed by HPLC and mass spectrometry) position it as a versatile protein purification tag compatible with diverse experimental buffers and challenging sample types.

For researchers exploring protein-protein interaction studies or tracking proteins in exosome pathway research, the HA tag peptide stands out for its reproducibility, sensitivity, and flexibility. As demonstrated in the landmark Cell Research study on RAB31, robust epitope tag-based detection is integral to unraveling the molecular machinery of exosome biogenesis and trafficking.

Step-by-Step Workflow: Enhancing Protein Detection and Purification

1. Fusion Protein Expression and Tagging

Start by cloning the HA tag DNA sequence (coding for YPYDVPDYA) at the N- or C-terminus of your target protein. Ensure correct insertion using sequence verification, referencing the standardized ha tag nucleotide sequence. Transfect or transform your host cell system (e.g., HEK293, CHO, yeast, or bacterial strains) and culture under optimal conditions for protein expression.

2. Cell Lysis and Preparation

Harvest cells and lyse using a buffer compatible with downstream applications (e.g., RIPA or NP-40 buffers) while maintaining protein integrity. The HA peptide’s high solubility ensures compatibility with aqueous and organic solvents, minimizing loss during extraction.

3. Immunoprecipitation with Anti-HA Antibody

• Incubate cleared lysate with immobilized anti-HA antibody (magnetic beads or agarose resin) for 1–2 hours at 4°C with gentle agitation. This step selectively enriches HA-tagged proteins via the hemagglutinin tag’s affinity.
• Wash beads thoroughly to remove non-specific binders. The peptide’s specificity for the anti-HA antibody ensures low background and high yield.

4. Competitive Elution with HA Tag Peptide

• Prepare an elution buffer containing 100–500 μg/mL of the Influenza Hemagglutinin (HA) Peptide. The optimal concentration may vary based on target abundance and antibody affinity.
• Incubate beads with the elution buffer for 30–60 minutes at 4°C. The free HA peptide outcompetes the HA fusion protein for antibody binding, enabling gentle, non-denaturing elution—a critical advantage over harsh chemical elution.
• Collect the eluate and proceed to downstream analyses (SDS-PAGE, western blot, mass spectrometry, etc.).

5. Detection and Quantitative Analysis

Analyze purified proteins using anti-HA antibody-based western blotting or immunofluorescence. The HA tag’s uniform sequence enables comparative quantification and multiplexing in protein-protein interaction studies.

Advanced Applications and Comparative Advantages

Exosome Pathway and Protein-Protein Interaction Studies

Recent advances, such as those highlighted by Wei et al. (Cell Research, 2021), underscore the importance of precise protein tracking in elucidating exosome biogenesis. In these studies, HA tag-based immunoprecipitation was pivotal in dissecting the roles of RAB31 and EGFR in ESCRT-independent exosome formation. The ability of the HA tag peptide to mediate efficient, non-denaturing elution preserves labile protein complexes and post-translational modifications—critical for sensitive exosome and signaling pathway analyses.

Comparing the Influenza Hemagglutinin (HA) Peptide to other epitope tags (e.g., FLAG, Myc), its high-affinity competitive elution and minimal cross-reactivity with endogenous proteins offer a lower background and higher specificity in complex samples. This is particularly valuable in cancer research and ubiquitination assays, as detailed in "Influenza Hemagglutinin (HA) Peptide: Precision Tag for P...", where the HA tag enables quantitative interaction profiling and detection even in low-abundance scenarios.

High-Purity, High-Solubility Tag for Workflow Versatility

The Influenza Hemagglutinin (HA) Peptide’s solubility (≥46.2 mg/mL in water) and purity (>98%) ensure it remains functional across a spectrum of buffers and storage conditions. This flexibility is discussed in "Influenza Hemagglutinin (HA) Peptide: Advanced Tag for Pr...", which complements this workflow by providing stepwise protocols for integrating the HA tag into cell viability, proliferation, and cytotoxicity assays.

Streamlining Troubleshooting and Reproducibility

As emphasized in "Solving Lab Workflow Challenges with Influenza Hemagglutinin (HA) Peptide", the consistent performance of APExBIO’s HA peptide minimizes batch-to-batch variability—a frequent pain point in large-scale or longitudinal studies. This reliability underpins its selection in high-throughput screening and sensitive cell signaling investigations.

Troubleshooting and Optimization Tips

• Low Yield in Elution: Increase the concentration of HA fusion protein elution peptide (up to 1 mg/mL), or extend incubation time. Ensure the anti-HA antibody is not saturated by excess lysate protein.
• High Background or Non-Specific Binding: Add additional wash steps with higher salt concentrations (e.g., 500 mM NaCl) or incorporate mild detergents. The specificity of the HA tag sequence minimizes off-target interactions, but optimization may be required for complex samples.
• Degraded or Aggregated Fusion Proteins: Maintain cold temperatures throughout the protocol and consider protease/phosphatase inhibitors. Store the Influenza Hemagglutinin (HA) Peptide desiccated at -20°C and prepare solutions fresh before use—long-term storage of peptide solutions is not recommended due to potential degradation or loss of activity.
• Suboptimal Detection in Western Blot: Optimize antibody dilution and incubation times. Use high-sensitivity detection reagents compatible with the hemagglutinin tag.
• Compatibility with Downstream Applications: The HA peptide is compatible with mass spectrometry, but ensure excess peptide is removed prior to analysis to avoid signal interference.

For a deeper dive into protocol enhancements and advanced troubleshooting, "Influenza Hemagglutinin (HA) Peptide: Optimizing HA Tag-Based Workflows" offers a comprehensive guide, extending these insights with data-driven benchmarks and user case studies.

Future Outlook: Expanding Horizons with the HA Tag Peptide

The evolution of exosome research, single-cell proteomics, and multiplexed protein interaction studies continues to increase the demand for reliable, high-purity molecular biology peptide tags. The Influenza Hemagglutinin (HA) Peptide’s proven performance in competitive binding to anti-HA antibody workflows positions it at the forefront of next-generation protein science.

Emerging applications include live-cell imaging of HA-tagged proteins, CRISPR-mediated endogenous tagging, and integration into microfluidic platforms for automated protein-protein interaction studies. Its role in dissecting complex signaling networks—as exemplified by ESCRT-independent exosome pathway research—will undoubtedly expand, especially as the need for reproducible, non-denaturing purification strategies grows.

Researchers are also leveraging the HA tag DNA sequence and ha tag nucleotide sequence for scalable, multiplexed tagging strategies, enabling simultaneous tracking of multiple proteins within dynamic cellular environments. This adaptability, coupled with the robust supply chain and quality assurance of APExBIO, ensures that the Influenza Hemagglutinin (HA) Peptide remains a cornerstone of molecular biology innovation.

Conclusion

The Influenza Hemagglutinin (HA) Peptide, available from APExBIO, embodies the ideal protein purification tag: high purity, unmatched solubility, and consistent, high-affinity competitive elution. By integrating this HA tag peptide into your immunoprecipitation, detection, and exosome research workflows, you gain access to reproducible, low-background results and new experimental possibilities. For additional insights and stepwise protocols, explore the complementary resources referenced throughout this guide and visit the product page for specifications and ordering details.